Impact Biomedical initiates research programme to solve the patent cliff
The primary cause of the patent crisis is that most techniques for modifying natural molecules to pharmaceutical grade products are essentially 'played out'
Breaking News
Pharmaseal reaches milestone in crowdfunding campaign
The company was first founded in 2016
Status update on ANDA for generic Advair Diskus (VR315 [US])
Vectura Group, an industry leading inhalation CDMO, confirms the announcement made by its partner Hikma Pharmaceuticals
Europital launches as a science-driven full service CRO
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries
What can the pharmaceutical industry do to ensure it’s ready for a future pandemic?
The COVID-19 pandemic has stretched healthcare suppliers, organisations, governments and medical professionals to their ...
End game for data integrity warning letters
Technology that supports paper to digital transition in pharma
HSG progresses PROOF-HD to Phase III clinical study
In a prior Phase II clinical study, PRIDE-HD, pridopidine administered orally twice a day was associated with ...
Enhancing clinical trial supply with JTM: part II
In a constantly changing world, the pharmaceutical industry is having to adopt its practices to serve the needs of a ...
Former FDA commissioner to deliver talk at CPhI Festival of Pharma
Dr Scott Gottlieb will address the industry on the topic of sustainable innovation
ERS Genomics comments on decisions in CRISPR/Cas9 interference case
The PTAB rejected a motion to prevent the interference from proceeding
Non-clinical safety evaluation of vaccines: accelerating clinical development (part II)
This white paper discusses regulatory expectations for the non-clinical development of vaccines, such as safety, ...
Optimise desiccants with 3D validation software
Baltimore's CFD model brings predictive science to validation. Desiccants are tested for performance over time, ...
Non-clinical safety evaluation of vaccines: accelerating clinical development (part I)
Sebastian Joseph, Principle Consultant, Director of Development Consulting and Scientific Affairs, PharmaLex, discusses ...
Pharma CEOs pledge to uphold scientific standards for COVID vaccine
The pledge outlines "a united commitment to uphold the integrity of the scientific process"
Catalent invests $50m at Bloomington facility
The line is expected to be operational by April 2021 and will add capacity to support the growing pipeline of clinical ...
In Brief
Most Popular in Regulatory
Featured Companies
Reports
